Titre:
  • Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies
Auteur:André, Marie Josèphe; Baudoux, Etienne; Bron, Dominique; Canon, Jean-Luc; D'Hondt, Véronique; Fassotte, Marie-France; D'Hondt, Lionel; Fillet, Georges; Humblet, Yves; Jerusalem, Guy; Vermeulen, Philippe; Symann, Michel; Beguin, Yves
Informations sur la publication:Transfusion, 43, 1, page (50-57)
Statut de publication:Publié, 2003-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- therapy
Female
Filgrastim -- pharmacology
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation -- adverse effects
Humans
Leukapheresis
Lymphoma -- therapy
Male
Middle Aged
Multiple Myeloma -- therapy
Transplantation, Autologous
Note générale:Clinical Trial
Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
FLWIN
Langue:Anglais
Identificateurs:urn:issn:0041-1132
info:doi/10.1046/j.1537-2995.2003.00273.x
info:pii/trf273
info:pmid/12519430